Advanced biocompatible filler containing 30% Poly-D,L-Lactide Acid (PDLLA) microspheres. Clinically proven to stimulate Type I collagen production with 85% patient satisfaction at 24-month follow-up. Provides dual-phase correction: immediate volume enhancement + progressive tissue remodeling lasting up to 60 months.

PDLLA Technology:
• 20-50μm microparticles (ISO 13485 certified)
• Gradual hydrolysis: 18-24 months absorption
• Stimulates 68% collagen increase*
*Based on 2023 clinical study (n=150)

Packaging:
📦 1 sterile vial
⚖ 1000mg PDLLA suspension
🧪 2ml carrier gel (CMC-based)
🏥 Single-patient use

Application Protocol:
1. Subdermal injection via 25G cannula
2. 0.5-1.0ml per treatment area
3. 4-6 week intervals (max 3 sessions)
4. Post-op massage protocol required

Medical Notice: Prescription-only device. Must be administered by licensed practitioners. Actual results may vary depending on tissue response and injection technique. Not for vascular/articular use. Contains no animal-derived components.